[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-521397-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-521397-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","risk-factors-and-development-of-a-predictive-score-model-for-tumor-lysis-syndrome-in-childhood-leukemia-a-10-year-experience-from-a-single-tertiary-hospital-in-thailand","Risk factors and development of a predictive score model for tumor lysis syndrome in childhood leukemia: a 10-year experience from a single tertiary hospital in Thailand","","Tumor lysis syndrome (TLS) in childhood leukemia was assessed retrospectively in 252 patients treated in a single tertiary center in Thailand from 2009 to 2019. Fifty-one patients (20.2%) developed TLS during induction chemotherapy; 60.7% were spontaneous TLS and 47% developed clinical TLS. A predictive score model used WBC count >50,000 cells/mm3, eGFR \u003C90, and AST >44 units/L. TLS rates increased across risk tiers (11.1%, 46.2%, 78.5%). Mortality during the first induction phase was higher with TLS, while 5-year overall survival did not differ significantly.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/risk-factors-and-development-of-a-predictive-score-model-for-tumor-lysis-syndrome-in-childhood-leukemia-a-10-year-experience-from-a-single-tertiary-hospital-in-thailand/521397/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/risk-factors-and-development-of-a-predictive-score-model-for-tumor-lysis-syndrome-in-childhood-leukemia-a-10-year-experience-from-a-single-tertiary-hospital-in-thailand/521397.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-10-07",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is tumor lysis syndrome (TLS) and when does it occur in childhood leukemia?","Question",{"text":63,"@type":64},"TLS is a potentially life-threatening condition that can occur after intensive chemotherapy in newly diagnosed hematologic malignancies, caused by a massive release of intracellular components such as potassium, phosphate, and uric acid.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was TLS evaluated in the study population?",{"text":68,"@type":64},"Researchers retrospectively reviewed medical records of pediatric patients with acute leukemia treated between January 2009 and December 2019, recording patient characteristics and outcomes during induction chemotherapy.",{"name":70,"@type":61,"acceptedAnswer":71},"What factors were included in the predictive score model for TLS risk?",{"text":72,"@type":64},"The model incorporated WBC count >50,000 cells/mm3, eGFR \u003C90, and aspartate transaminase (AST) >44 units/L.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},521397,1791722372,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Leukemia & Lymphoma  \nISSN: (Print) (Online) Journal [homepage: ](homepage: www.tandfonline.com/journals/ilal20)[www.tandfonline.com/journals/ilal20](homepage: www.tandfonline.com/journals/ilal20)  \nRisk factors and development of a predictive score model for tumor lysis syndrome in childhood leukemia: a 10-year experience from a single tertiary hospital in Thailand  \nPharsai Prasertsan, Edward B. McNeil, Natsaruth Songthawee, Shevachut Chavananon, Pornpun Sripornsawan, Thampapon Chaisujyakorn & Thirachit Chotsampancharoen  \nTo cite this article: Pharsai Prasertsan, Edward B. McNeil, Natsaruth Songthawee, Shevachut Chavananon, Pornpun Sripornsawan, Thampapon Chaisujyakorn & Thirachit Chotsampancharoen (18 Aug 2024): Risk factors and development of a predictive score model for tumor lysis syndrome in childhood leukemia: a 10-year experience from a single tertiary hospital in Thailand, Leukemia & Lymphoma, DOI: 10.1080/10428194.2024.2390582  \nTo link to this article: [https://doi.org/10.1080/10428194.2024.2390582](https://doi.org/10.1080/10428194.2024.2390582)  \n View supplementary material   \n\n|  Published online: 18 Aug 2024. |\n| --- |\n|  Submit your article to this journal  |\n|  View related articles  |\n|  View Crossmark data |\n\nFull Terms & Conditions of access and use can be found at [https://www.tandfonline.com/action/journalInformation?journalCode=ilal20](https://www.tandfonline.com/action/journalInformation?journalCode=ilal20)  \nLeukemia & Lymphoma  \n[https://doi.org/10.1080/10428194.2024.2390582](https://doi.org/10.1080/10428194.2024.2390582)  \nRisk factors and development of a predictive score model for tumor lysis syndrome in childhood leukemia: a 10-year experience from a single tertiary hospital in Thailand  \nPharsai Prasertsana , Edward B. McNeilb , Natsaruth Songthaweec , Shevachut Chavananonc , Pornpun Sripornsawanc , Thampapon Chaisujyakornd and Thirachit Chotsampancharoenc   \naDepartment of pediatrics, Division of pediatric Critical Care medicine, prince of Songkla university, hat yai, Thailand; bepidemiology unit, Faculty of medicine, prince of Songkla university, hat yai, Thailand; cDepartment of pediatrics, Division of hematology and oncology, prince of Songkla university, hat yai, Thailand; dDepartment of pediatrics, prince of Songkla university, hat yai, Thailand  \nABSTRACT  \nTumor lysis syndrome (TLS) in childhood leukemia was assessed retrospectively in 252 patients ina single tertiary center in Thailand during 2009–2019. Fifty-one (20.2%) developed TLS during their induction chemotherapy; 60.7%(31/51) were spontaneous TLS and 47%(24/51) developed clinical TLS. The predictive score model consisted of white blood cell (WBC) count more than 50,000 cells/mm3, glomerular filtration rate less than 90, and aspartate transaminase more than 44 units/L. The TLS development rates were 11.1%, 46.2%, and 78.5% in the low, intermediate, and high-risk groups, respectively. Death during the first induction phase in patients with TLS was significantly higher than in the patients without TLS. However, the 5-year overall survival rates for the children with and without TLS were not significantly different.  \nARTICLE HISTORY  \nReceived 27 February 2024 Accepted 5 August 2024  \nKEYWORDS  \nComplications; leukemia; mortality; risk factors; tumor lysis syndrome  \nIntroduction  \nTumor lysis syndrome (TLS) is a potentially life-threatening condition which can occur following intensive chemotherapy in a newly diagnosed hematologic malignancy. It is caused by massive release of cell components, such as potassium, phosphate, and uric acid. The reported incidence of this condition in leukemic children varies widely from 1.4% to 53.6%[1–3], with one study reporting TLS-related death rates of 5.1% [4] . Standard preventative strategies include vigorous intravenous hydration, urine alkalinization, and uric reduction with allopurinol to prevent acute kidney injury [5] . Although a risk stratification system [5] has been available for ma","cbCaimOiM8qakQp9","https://ap.wps.com/l/cbCaimOiM8qakQp9","pdf",1510825,"English","# Abstract\n# Introduction\n# Materials and methods\n## Patients and data collection\n# Article history\n# Keywords","[{\"question\":\"What is tumor lysis syndrome (TLS) and when does it occur in childhood leukemia?\",\"answer\":\"TLS is a potentially life-threatening condition that can occur after intensive chemotherapy in newly diagnosed hematologic malignancies, caused by a massive release of intracellular components such as potassium, phosphate, and uric acid.\"},{\"question\":\"How was TLS evaluated in the study population?\",\"answer\":\"Researchers retrospectively reviewed medical records of pediatric patients with acute leukemia treated between January 2009 and December 2019, recording patient characteristics and outcomes during induction chemotherapy.\"},{\"question\":\"What factors were included in the predictive score model for TLS risk?\",\"answer\":\"The model incorporated WBC count \\u003e50,000 cells/mm3, eGFR \\u003c90, and aspartate transaminase (AST) \\u003e44 units/L.\"}]","Risk factors and development of a predictive score model for tumor lysis syndrome in childhood leukemia: a 10-year experience from a single tertiary hospital in Thailand | PDF",1791407183,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/da2fae0d7cd439490c1d5b93139be25c.webp",983,1290,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/832223625245774e82a2b2d3801ac0a4.webp",982,1278,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/516714a6baec49ba4d3e5b4cc30385cc.webp",981,1277,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/3521afbcf809db3467fcb1663b1c5d8a.webp",980,1276]